MA43978A - Dérivé de sulfonamide hétérocyclique et médicament le contenant - Google Patents
Dérivé de sulfonamide hétérocyclique et médicament le contenantInfo
- Publication number
- MA43978A MA43978A MA043978A MA43978A MA43978A MA 43978 A MA43978 A MA 43978A MA 043978 A MA043978 A MA 043978A MA 43978 A MA43978 A MA 43978A MA 43978 A MA43978 A MA 43978A
- Authority
- MA
- Morocco
- Prior art keywords
- product containing
- medicinal product
- sulfonamide derivative
- heterocyclic sulfonamide
- heterocyclic
- Prior art date
Links
- HFFXLYHRNRKAPM-UHFFFAOYSA-N 2,4,5-trichloro-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(Cl)C=2)Cl)=N1 HFFXLYHRNRKAPM-UHFFFAOYSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016021358 | 2016-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43978A true MA43978A (fr) | 2018-12-12 |
Family
ID=59499709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043978A MA43978A (fr) | 2016-02-05 | 2017-02-03 | Dérivé de sulfonamide hétérocyclique et médicament le contenant |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10584116B2 (fr) |
| EP (1) | EP3412664B1 (fr) |
| JP (1) | JP6906449B2 (fr) |
| KR (1) | KR102766396B1 (fr) |
| CN (1) | CN108602807B (fr) |
| AU (1) | AU2017213993B2 (fr) |
| CA (1) | CA3012812A1 (fr) |
| DK (1) | DK3412664T3 (fr) |
| EA (1) | EA037264B1 (fr) |
| ES (1) | ES2911416T3 (fr) |
| MA (1) | MA43978A (fr) |
| MX (1) | MX379373B (fr) |
| PL (1) | PL3412664T3 (fr) |
| WO (1) | WO2017135462A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7043483B2 (ja) * | 2016-07-20 | 2022-03-29 | エフ．ホフマン－ラ ロシュ アーゲー | 二環式プロリン化合物 |
| FR3114235A1 (fr) | 2020-09-18 | 2022-03-25 | Université Grenoble Alpes | Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer |
| IT202100015098A1 (it) | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
| WO2023033097A1 (fr) * | 2021-09-02 | 2023-03-09 | Ｅａファーマ株式会社 | Procédé de production d'un dérivé de sulfonamide hétérocyclique et intermédiaire synthétique de celui-ci |
| EP4617267A4 (fr) * | 2022-11-10 | 2026-02-18 | Prime Gene Therapeutics Co Ltd | Composé thioéther ayant une propriété de médicament doux et son utilisation, composition pharmaceutique et utilisation associées |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017612B2 (en) * | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| US8614201B2 (en) | 2009-06-05 | 2013-12-24 | Janssen Pharmaceutica Nv | Heterocyclic amides as modulators of TRPA1 |
| EP2520566A1 (fr) * | 2011-05-06 | 2012-11-07 | Orion Corporation | Nouveaux composés pharmaceutiques |
| EP2805718B1 (fr) | 2012-01-17 | 2018-04-04 | EA Pharma Co., Ltd. | Dérivé d'amine hétérocyclique et produit pharmaceutique le contenant |
| BR112015006737A2 (pt) * | 2012-09-27 | 2017-07-04 | Hoffmann La Roche | compostos de sulfonamida substituídos |
| EP2937335A4 (fr) | 2012-12-18 | 2016-09-14 | Ea Pharma Co Ltd | Dérivé d'amide hétérocyclique et médicament le contenant |
| EP2774919A1 (fr) | 2013-03-06 | 2014-09-10 | Pharmeste S.R.L. In Liquidazione | Nouveaux antagonistes des récepteurs TRPA1 de sulfonamide |
| PL3055302T3 (pl) * | 2013-10-11 | 2019-05-31 | Hoffmann La Roche | Podstawione związki heterocykliczne sulfonamidowe użyteczne jako modulatory TRPA1 |
| AU2015211852A1 (en) * | 2014-01-28 | 2016-09-15 | Ea Pharma Co., Ltd. | Heterocyclic sulfonamide derivative and medicine comprising same |
| WO2016128529A1 (fr) | 2015-02-15 | 2016-08-18 | F. Hoffmann-La Roche Ag | Dérivés de 1-(het)arylsulfonyle- (pyrrolidine ou pipéridine)-2-carboxamide et leur utilisation comme antagonistes de trpa1 |
| WO2017018495A1 (fr) | 2015-07-29 | 2017-02-02 | Ｅａファーマ株式会社 | Dérivé cyclopropane et médicament le contenant |
-
2017
- 2017-02-03 PL PL17747613T patent/PL3412664T3/pl unknown
- 2017-02-03 DK DK17747613.2T patent/DK3412664T3/da active
- 2017-02-03 ES ES17747613T patent/ES2911416T3/es active Active
- 2017-02-03 MA MA043978A patent/MA43978A/fr unknown
- 2017-02-03 MX MX2018009458A patent/MX379373B/es unknown
- 2017-02-03 AU AU2017213993A patent/AU2017213993B2/en active Active
- 2017-02-03 JP JP2017565677A patent/JP6906449B2/ja not_active Expired - Fee Related
- 2017-02-03 WO PCT/JP2017/004134 patent/WO2017135462A1/fr not_active Ceased
- 2017-02-03 CN CN201780009998.3A patent/CN108602807B/zh active Active
- 2017-02-03 CA CA3012812A patent/CA3012812A1/fr active Pending
- 2017-02-03 EA EA201891782A patent/EA037264B1/ru unknown
- 2017-02-03 KR KR1020187025206A patent/KR102766396B1/ko active Active
- 2017-02-03 EP EP17747613.2A patent/EP3412664B1/fr active Active
-
2018
- 2018-08-03 US US16/054,077 patent/US10584116B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190023699A1 (en) | 2019-01-24 |
| AU2017213993B2 (en) | 2021-03-25 |
| CA3012812A1 (fr) | 2017-08-10 |
| WO2017135462A1 (fr) | 2017-08-10 |
| JPWO2017135462A1 (ja) | 2018-12-13 |
| MX2018009458A (es) | 2018-09-21 |
| EA037264B1 (ru) | 2021-03-01 |
| KR102766396B1 (ko) | 2025-02-13 |
| EA201891782A1 (ru) | 2019-06-28 |
| EP3412664A4 (fr) | 2019-10-16 |
| KR20180104150A (ko) | 2018-09-19 |
| PL3412664T3 (pl) | 2022-06-06 |
| DK3412664T3 (da) | 2022-06-07 |
| JP6906449B2 (ja) | 2021-07-21 |
| BR112018015851A2 (pt) | 2018-12-26 |
| MX379373B (es) | 2025-03-10 |
| CN108602807B (zh) | 2022-05-13 |
| CN108602807A (zh) | 2018-09-28 |
| EP3412664A1 (fr) | 2018-12-12 |
| US10584116B2 (en) | 2020-03-10 |
| EP3412664B1 (fr) | 2022-03-30 |
| ES2911416T3 (es) | 2022-05-19 |
| AU2017213993A1 (en) | 2018-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3440058A4 (fr) | Composé électro-polarisable et condensateur | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| EP3727531C0 (fr) | Nébuliseur et cartouche | |
| PT3500255T (pt) | Composições farmacêuticas oftálmicas e utilizações relacionadas com estas | |
| EP4209238C0 (fr) | Nébuliseur et cartouche | |
| EP3351533A4 (fr) | Dérivé biaryle et médicament le contenant | |
| EP3424940A4 (fr) | Médicament radiomarqué | |
| EP3328401A4 (fr) | Protéine 2 contenant le domaine de sperme motile et cancer | |
| EP3101015A4 (fr) | Dérivé de sulfonamide hétérocyclique et médicament le contenant | |
| EP3525841A4 (fr) | Micro-dispositif d'administration | |
| CL2019000563S1 (es) | Envase y dispendio de medicamentos. (divisional solicitud 201800718) | |
| EP3437644A4 (fr) | Médicament | |
| EP3456311A4 (fr) | Produit cosmétique | |
| EP3403642A4 (fr) | Produit cosmétique | |
| EP3556771A4 (fr) | Anticorps de claudine 5 et médicament le contenant | |
| MA43978A (fr) | Dérivé de sulfonamide hétérocyclique et médicament le contenant | |
| EP3434681A4 (fr) | Complexe de curcumine-bore et agent pharmaceutique le contenant | |
| IL282157A (en) | Compounds and therapeutic uses thereof | |
| EP3527216A4 (fr) | Médicament | |
| EP3474836C0 (fr) | Médicament ophtalmique contenant du salbutamol. | |
| PL4023651T3 (pl) | Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca | |
| EP3442618A4 (fr) | Chargement d'article jetable | |
| DK3426681T3 (da) | Åbne hla-b57-konformere | |
| HUE053974T2 (hu) | Szemészeti gyógyászati készítmény | |
| MA46642A (fr) | Promédicaments d'inhibiteurs de la kallicréine |